Clinical Trials Directory

Trials / Completed

CompletedNCT04547959

Prospective Clinical Study to Evaluate the Efficacy of the Stand-alone Cervical Interbody Cage C-CURVE ( Titanium) Manufactured by MEDICREA®

Prospective Clinical Study to Evaluate the Efficacy of the Stand-alone Cervical Interbody Cage C-CURVE (Titanium) Manufactured by MEDICREA®

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
82 (actual)
Sponsor
Medicrea International · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study includes one type of product named C-CURVE which is a Stand-alone Cervical Interbody Cage. This product is available in two materials: PEEK and Titanium. The C-Curve Cervical Interbody Devices is one single implant used for insertion between two adjacent vertebrae (cervical spine). C-Curve has been designed to restore and/or maintain adequate interbody height, and thus help stabilize one or more cervical levels while fusion occurs. This system has also as objectives to increase of the quality of life, decrease patient's pain and decrease a potential dysphagia (clinical performances). This system must only be used in the cervical spine. This post-market clinical follow-up (PMCF) study aims to confirm the acceptable benefits/risk profile of the device for the patients and to fill essential requirements to maintain the CE mark through a clinical evaluation.

Conditions

Interventions

TypeNameDescription
DEVICEcervical interbody cage C-CURVEACDF: Anterior Cervical Discectomy and Fusion with a C-CURVE cage

Timeline

Start date
2020-11-20
Primary completion
2024-10-01
Completion
2024-10-01
First posted
2020-09-14
Last updated
2025-01-13

Locations

10 sites across 2 countries: Belgium, France

Source: ClinicalTrials.gov record NCT04547959. Inclusion in this directory is not an endorsement.